Kolexia
Thomassin-Defachelles Anne-Sophie
Pédiatrie
Centre Oscar-Lambret
Lille, France
129 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Neuroblastome Rhabdomyosarcome Sarcomes Récidive tumorale locale Fibromatose agressive Fibrome Sarcome d'Ewing Tumeurs des tissus mous Tumeurs osseuses

Industries

Eusa Pharma
1 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
European journal of cancer (Oxford, England : 1990)   15 février 2024
NEUROBLU 02: A Phase I Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.
Essai Clinique (Advanced Accelerator Applications)   13 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta: A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta
Essai Clinique (Eusa Pharma)   06 février 2024
Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript.
The British journal of radiology   16 janvier 2024
Phase I/II study of the WEE1 inhibitor adavosertib (AZD1775) in combination with carboplatin in children with advanced malignancies: Arm C of the AcSé-ESMART trial.
Clinical cancer research : an official journal of the American Association for Cancer Research   05 décembre 2023
SHOULD WE CONSIDER ALVEOLAR SOFT PART SARCOMAS IN CHILDREN AND YOUNG ADULTS IN THE SAME WAY? THE FRENCH NATIONAL NETSARC+ NETWORK EXPERIENCE
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   02 novembre 2023
ASSESSMENT OF A NOVEL READY-TO-USE TEMOZOLOMIDE ORAL SUSPENSION IN CHILDREN WITH SOLID TUMORS: RESULTS OF TEMOKIDS, A POPULATION PHARMACOKINETIC, ACCEPTABILITY AND SAFETY PHASE-1 STUDY
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
THERAPY AND OUTCOME OF PATIENTS WITH RELAPSE OF NONMETASTATIC RHABDOMYOSARCOMA: A REPORT FROM THE FRENCH SOCIETY OF PEDIATRIC ONCOLOGY (SFCE) MALIGNANT MESENCHYMAL TUMOR (MMT) COMMITTEE
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023